MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Effects of Apomorphine infusion on Head ptosis, a case report

O. Skogar (Stockholm, Sweden)

Meeting: 2019 International Congress

Abstract Number: 207

Keywords: Apomorphine, Posture

Session Information

Date: Monday, September 23, 2019

Session Title: Clinical Trials, Pharmacology and Treatment

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Sustained Effects of Apomorphine infusion on Head Ptosis, a case report

Background: IntroductionHead ptosis (Hp) results from weakness of the neck extensor, or increased tone of the flexor muscles1. Hp can be caused by specific generalized neuromuscular diagnoses, MG, ALS or polymyositis. Sometimes Hp is seen in association with camtocormia.Definite pathophysiological diagnose is often not possible. It can be a part of PS with a reported prevalence of 3 to 17,6%

Method: Intermittent infusion with apomorphine (Daceptone™) showed  positive effects on  Hp and pump therapy 16h/day was initiated.

Results: Longstanding effects were seen >2 months, so far.

Conclusion: Apomorphine infusion therapy can be considered in patients suffering from severe Head drop as a part of a parkinsonian syndrome.

References: References: 1. Abe K, Uchida Y, Notani M. Camptocormia in Parkinson’s disease. Parkinsons Dis. 2010;2010. 2. Umapathi T, Chaudhry V, Cornblath D, Drachman D, Griffin J, Kuncl R. Head drop and camptocormia. Journal of Neurology, Neurosurgery & Psychiatry. 2002;73(1):1. 3. Margraf NG, Wrede A, Deuschl G, Schulz-Schaeffer WJ. Pathophysiological Concepts and Treatment of 2015;122(6):835-9. Camptocormia. J Parkinsons Dis. 2016;6(3):485-501. 4. Mensikova K, Kaiserova M, Vastik M, Kurcova S, Kanovsky P. Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study. J Neural Transm (Vienna).

To cite this abstract in AMA style:

O. Skogar. The Effects of Apomorphine infusion on Head ptosis, a case report [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/the-effects-of-apomorphine-infusion-on-head-ptosis-a-case-report/. Accessed July 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-effects-of-apomorphine-infusion-on-head-ptosis-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley